丝素
药物输送
微流控
纳米技术
微球
细胞毒性
药品
材料科学
靶向给药
生物医学工程
毒品携带者
微流控芯片
生物相容性材料
控制释放
化学
制作
药理学
纳米生物技术
自愈水凝胶
肺表面活性物质
作者
Tianyuan Zhang,Bingyu Cai,Fengyuan Zhang,Min Wang
摘要
cytotoxicity assays showed slightly reduced A549 cell viability (<80%) due to dexamethasone's antiproliferative activity, the SFD exhibited minimal cytotoxicity (>95%) toward RAW264.7 macrophages. Furthermore, in a pro-inflammatory model, the SFD significantly suppressed secretion of key inflammatory cytokines including IL-1β, IL-6, and TNF-α, while minimizing systemic side effects through localized anti-inflammatory activity. This work addresses limitations of traditional pulmonary drug delivery systems by integrating microfluidic precision, controlled release, and targeted delivery into a biocompatible platform. By reducing off-target toxicity and enhancing therapeutic localization, the SFD system represents a transformative strategy for pulmonary inflammation treatment. The findings underscore the potential of microfluidic technologies to revolutionize precision medicine in respiratory therapeutics, with implications for clinical translation and personalized treatment protocols.
科研通智能强力驱动
Strongly Powered by AbleSci AI